Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Hospira Inc. Stories

2014-03-31 16:26:44

LAKE FOREST, Ill., March 31, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its first-quarter 2014 results on Wednesday, April 30, 2014 at 8 a.m. Central time. The company will release its first-quarter results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call and related material will be available...

2014-03-27 12:30:10

LAKE FOREST, Ill., March 27, 2014 /PRNewswire/ -- Hospira (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that, for the second consecutive year, its TheraDoc(TM) Infection Control Assistant(TM) software has been ranked as the top product in the Infection Control & Monitoring software category in the recently released Best in KLAS Awards 2013: Software and Services Report (more information available at www.theradoc.com). The...

2014-03-13 16:25:38

LONDON, March 13, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 This report studies the market for intravenous (IV) access devices utilized by physicians to deliver medication to the patients' bloodstream through the intravenous route and also to withdraw blood...

2014-03-04 12:25:25

-- Endicott brings extensive industry experience and vision to advance company's device strategy and drive global growth -- LAKE FOREST, Ill., March 4, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that David J. Endicott has been named President, Hospira Medical Devices, effective March 10, 2014. In this newly created role, Mr. Endicott will have responsibility for establishing a fully...

2014-02-10 16:26:38

LAKE FOREST, Ill., Feb. 10, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at two upcoming conferences: -- Raymond James 35(th )Institutional Investors ConferenceMarch 4, 2014 (Tuesday) - Orlando, Fla. 8:40 a.m. Eastern time -- Barclays Capital 2014 Global Healthcare ConferenceMarch 12, 2014 (Wednesday) - Miami8:00 a.m. Eastern time The...

2014-01-09 16:24:57

LAKE FOREST, Ill., Jan. 9, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its fourth-quarter and full-year 2013 results and projections for 2014 on Wednesday, Feb. 12, 2014 at 8 a.m. Central time. The company will release its fourth-quarter and full-year results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the...

2013-12-17 16:23:08

LAKE FOREST, Ill., Dec. 17, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the J.P. Morgan 32nd Annual Healthcare Conference on Wednesday, Jan. 15, 2014, in San Francisco. The presentation is scheduled to begin at 10:30 a.m. Pacific time on Wednesday, Jan. 15, 2014. It will be available to all interested parties through a live audiocast accessible via the...

2013-11-26 12:27:07

LAKE FOREST, Ill., Nov. 26, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE:HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that it will host an Investor Day at the company's headquarters on Thursday, Dec. 5, 2013. Presenting at the event will be F. Michael Ball, Hospira's chief executive officer, and several members of the company's senior management. A streaming audio webcast of the event, together with the slide presentations, will be...

2013-11-06 08:29:11

-- Reaffirms adjusted* sales and adjusted* earnings ranges for 2013 -- LAKE FOREST, Ill., Nov. 6, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the third quarter ended Sept. 30, 2013. Net sales for the quarter were $1.0 billion and adjusted* diluted earnings per share were $0.51. (Adjusted* measures exclude certain specified items as described later in this press release and the...

2013-10-31 12:27:22

-- Results presented as late breaker at American College of Rheumatology -- LAKE FOREST, Ill., Oct. 31, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, this week shared the results of two open-label extension studies of CT-P13 (infliximab), one in patients with rheumatoid arthritis, the other in patients with ankylosing spondylitis, which were presented at the 2013 American College of Rheumatology (ACR)/Association of...